%0 Journal Article
%T Can a standard dose of eicosapentaenoic acid (EPA) supplementation reduce the symptoms of delayed onset of muscle soreness?
%A David Houghton
%A Gladys L Onambele
%J Journal of the International Society of Sports Nutrition
%D 2012
%I BioMed Central
%R 10.1186/1550-2783-9-2
%X Seventeen healthy non-smoking females (age 20.4 ¡À 2.1 years, height 161.2 ¡À 8.3 cm and mass 61.48 ¡À 7.4 kg) were randomly assigned to either placebo (N = 10) or EPA (N = 7). Serum IL-6, isometric and isokinetic (concentric and eccentric) strength, and rating of perceived exertion (RPE) were recorded on four occasions: i-prior to supplementation, ii-immediately after three weeks of supplementation (basal effects), iii-48 hours following a single bout of resistance exercise (acute training response effects), and iv-48 hours following the last of a series of three bouts of resistance exercise (chronic training response effects).There was only a group difference in the degree of change in circulating IL-6 levels. In fact, relative to the first baseline, by the third bout of eccentric workout, the EPA group had 103 ¡À 60% increment in IL-6 levels whereas the placebo group only had 80 ¡À 26% incremented IL-6 levels (P = 0.020). We also describe a stable multiple linear regression model which included measures of strength and not IL-6 as predictors of RPE scale.The present study suggests that in doubling the standard recommended dose of EPA, whilst this may still not be beneficial at ameliorating the symptoms of DOMS, it counter intuitively appears to enhance the cytokine response to exercise. In a context where previous in vitro work has shown EPA to decrease the effects of inflammatory cytokines, it may in fact be that the doses required in vivo is much larger than current recommended amounts. An attempt to dampen the exercise-induced cytokine flux in fact results in an over-compensatory response of this system.Although exercise is generally shown to be beneficial, a bout of resistance exercise that an individual is unaccustomed to can result in a reduction in force generating capacity (RFGC) and post-exercise muscle soreness, commonly known as Delayed Onset Muscle Soreness or DOMS [1,2]. There is no known definitive cause of DOMS, although Lenn et al. [3] suggested that t
%K EPA
%K IL-6
%K resistance exercise and Delayed Onset Muscle Soreness
%U http://www.jissn.com/content/9/1/2